Published in J Cell Mol Med on May 02, 2013
Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway. Lab Invest (2014) 0.89
Endotoxin induces fibrosis in vascular endothelial cells through a mechanism dependent on transient receptor protein melastatin 7 activity. PLoS One (2014) 0.82
EOLA1 protects lipopolysaccharide induced IL-6 production and apoptosis by regulation of MT2A in human umbilical vein endothelial cells. Mol Cell Biochem (2014) 0.80
Endotoxin-induced endothelial fibrosis is dependent on expression of transforming growth factors β1 and β2. Infect Immun (2014) 0.77
Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein. Crit Care (2014) 0.75
Naringin inhibits lipopolysaccharide-induced damage in human umbilical vein endothelial cells via attenuation of inflammation, apoptosis and MAPK pathways. Cytotechnology (2016) 0.75
Endothelial fibrosis induced by suppressed STAT3 expression mediated by signaling involving the TGF-β1/ALK5/Smad pathway. Lab Invest (2017) 0.75
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
The pathophysiology and treatment of sepsis. N Engl J Med (2003) 21.67
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 14.01
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol (2008) 5.83
Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res (2005) 5.08
EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest (2009) 4.41
The enigma of sepsis. J Clin Invest (2003) 4.32
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res (2007) 3.86
The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) (2004) 3.32
Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (2009) 2.68
TGF-beta receptor function in the endothelium. Cardiovasc Res (2005) 2.68
The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer (2008) 2.67
Lipopolysaccharide signaling in endothelial cells. Lab Invest (2006) 2.58
The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today (1999) 2.37
The impact of the extracellular matrix on inflammation. Nat Rev Immunol (2010) 2.30
Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol (2004) 2.30
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
The specificities of small molecule inhibitors of the TGFß and BMP pathways. Cell Signal (2011) 1.93
TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) (2011) 1.90
The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep (2006) 1.78
Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol (2003) 1.71
A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc (2007) 1.70
Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol (2010) 1.68
Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem J (2011) 1.65
Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 1.64
Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J Hypertens (2009) 1.56
Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res (2003) 1.50
Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis. Front Biosci (2008) 1.44
Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol (2009) 1.29
NAD(P)H oxidase-derived H(2)O(2) signals chloride channel activation in cell volume regulation and cell proliferation. J Biol Chem (2004) 1.27
Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells. J Biol Chem (2002) 1.20
Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care (2003) 1.18
Dysregulation of the immune response in severe sepsis. Am J Med Sci (2004) 1.17
Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res (2010) 1.17
Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res (2007) 1.15
Endothelial progenitor cells (EPC) in sepsis with acute renal dysfunction (ARD). Crit Care (2011) 1.11
Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol (2007) 1.11
Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. Eur J Pharmacol (1996) 1.05
Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell Signal (2012) 1.05
Proteomic study of human umbilical vein endothelial cells in culture. Proteomics (2003) 1.04
Endothelial responses to bacterial toxins in sepsis. Crit Rev Immunol (2003) 1.03
Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death. Cardiovasc Res (2011) 1.00
Oxidative stress and endothelial dysfunction during sepsis. Front Biosci (Landmark Ed) (2011) 0.96
IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. Immunobiology (2012) 0.95
Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Int J Biochem Cell Biol (2012) 0.94
Hydrogen peroxide removes TRPM4 current desensitization conferring increased vulnerability to necrotic cell death. J Biol Chem (2010) 0.93
TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. J Cell Sci (2005) 0.93
Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid Redox Signal (2011) 0.91
Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials (2008) 0.90
Protein kinase C-mediated phosphorylation of p47 phox modulates platelet-derived growth factor-induced H2O2 generation and cell proliferation in human umbilical vein endothelial cells. Endothelium (2008) 0.90
Endotoxin-induced changes of endothelial cell viability and permeability: protective effect of a 21-aminosteroid. Eur J Pharmacol (1995) 0.90
Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway. Cell Signal (2010) 0.88
New treatment strategies for severe sepsis and septic shock. Curr Opin Crit Care (2003) 0.84
Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Biochem Biophys Res Commun (2011) 0.83
Hydroxyl radical activation of a Ca(2+)-sensitive nonselective cation channel involved in epithelial cell necrosis. Am J Physiol Cell Physiol (2004) 0.83
Markers of endothelial dysfunction. Clin Chem Lab Med (2000) 0.82
Non-selective cation channels and oxidative stress-induced cell swelling. Biol Res (2002) 0.81
The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev (2003) 3.48
High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS One (2011) 2.82
NAD(P)H oxidase-derived H(2)O(2) signals chloride channel activation in cell volume regulation and cell proliferation. J Biol Chem (2004) 1.27
Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation. Matrix Biol (2006) 1.27
Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation. J Cell Sci (2003) 1.17
Release of gliotransmitters through astroglial connexin 43 hemichannels is necessary for fear memory consolidation in the basolateral amygdala. FASEB J (2012) 1.17
Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling. Hum Mol Genet (2013) 1.03
CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J Pathol (2011) 1.02
Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol (2008) 1.01
Transient receptor potential melastatin 4 inhibition prevents lipopolysaccharide-induced endothelial cell death. Cardiovasc Res (2011) 1.00
Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation. J Cell Physiol (2008) 0.94
The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin. J Biol Chem (2006) 0.94
Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells. Int J Biochem Cell Biol (2012) 0.94
De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy. Proc Natl Acad Sci U S A (2013) 0.92
Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2). Cell Tissue Res (2013) 0.91
Increased expression of the transient receptor potential melastatin 7 channel is critically involved in lipopolysaccharide-induced reactive oxygen species-mediated neuronal death. Antioxid Redox Signal (2011) 0.91
Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet (2013) 0.90
Involvement of the insular cortex in retention of conditioned taste aversion is not time dependent. Neurobiol Learn Mem (2010) 0.90
Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons. Mol Cell Neurosci (2013) 0.88
Oxidative stress-modulated TRPM ion channels in cell dysfunction and pathological conditions in humans. Cell Signal (2013) 0.87
TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation. Exp Cell Res (2010) 0.86
The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice. Pflugers Arch (2014) 0.86
TRPM4 enhances cell proliferation through up-regulation of the β-catenin signaling pathway. J Cell Physiol (2011) 0.86
Activation of H2O2-induced VSOR Cl- currents in HTC cells require phospholipase Cgamma1 phosphorylation and Ca2+ mobilisation. Cell Physiol Biochem (2007) 0.85
Renin-angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev (2015) 0.84
Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism. Clin Sci (Lond) (2015) 0.84
The role of the insular cortex in taste function. Neurobiol Learn Mem (2011) 0.84
Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells. Biochem Biophys Res Commun (2011) 0.83
Hemichannels in the neurovascular unit and white matter under normal and inflamed conditions. CNS Neurol Disord Drug Targets (2011) 0.83
The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle. Clin Sci (Lond) (2014) 0.83
Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. Biofactors (2013) 0.81
Lipopolysaccharide signaling in the carotid chemoreceptor pathway of rats with sepsis syndrome. Respir Physiol Neurobiol (2010) 0.81
Copper deficiency alters cell bioenergetics and induces mitochondrial fusion through up-regulation of MFN2 and OPA1 in erythropoietic cells. Biochem Biophys Res Commun (2013) 0.81
Expression of the Mas receptor is upregulated in skeletal muscle wasting. Histochem Cell Biol (2014) 0.80
Ca2+-activated K+ channels of small and intermediate conductance control eNOS activation through NAD(P)H oxidase. Free Radic Biol Med (2011) 0.80
Nutritional status modulates plasma leptin, AMPK and TOR activation, and mitochondrial biogenesis: Implications for cell metabolism and growth in skeletal muscle of the fine flounder. Gen Comp Endocrinol (2013) 0.78
Adaptive responses of mitochondria to mild copper deprivation involve changes in morphology, OXPHOS remodeling and bioenergetics. J Cell Physiol (2014) 0.78
Functional role of connexins and pannexins in the interaction between vascular and nervous system. J Cell Physiol (2014) 0.78
P2X4 activation modulates volume-sensitive outwardly rectifying chloride channels in rat hepatoma cells. J Biol Chem (2010) 0.78
Excess iodide induces an acute inhibition of the sodium/iodide symporter in thyroid male rat cells by increasing reactive oxygen species. Endocrinology (2015) 0.77
Suppression of transient receptor potential melastatin 4 expression promotes conversion of endothelial cells into fibroblasts via transforming growth factor/activin receptor-like kinase 5 pathway. J Hypertens (2015) 0.77
Polarized trafficking of thyrocyte proteins in MDCK cells. Mol Cell Endocrinol (2002) 0.76
Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock. J Trauma Acute Care Surg (2012) 0.75
Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies. Biofactors (2015) 0.75
Angiotensin-(1-7) Prevents Skeletal Muscle Atrophy Induced by Transforming Growth Factor Type Beta (TGF-β) via Mas Receptor Activation. Cell Physiol Biochem (2016) 0.75